Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

Aim: To verify the superiority of pemafibrate over placebo and the non-inferiority of pemafibrate to the maximum dose of fenofibrate for determining the percent change in fasting serum triglyceride (TG) levels and to investigate safety by assessing the incidence of adverse events (AEs) and adverse d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Atheroscler Thromb
Autors principals: Arai, Hidenori, Yamashita, Shizuya, Yokote, Koutaro, Araki, Eiichi, Suganami, Hideki, Ishibashi, Shun
Format: Artigo
Idioma:Inglês
Publicat: Japan Atherosclerosis Society 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6005227/
https://ncbi.nlm.nih.gov/pubmed/29628483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.44412
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars